Natural evolution of experimental vitreous hemorrhage and effects of corticosteroids on its course by Vuković Dragan
  
732
  
Srp Arh Celok Lek. 2013 Nov-Dec;141(11-12):732-737  DOI: 10.2298/SARH1312732V
ОРИГИНАЛНИ РАД / ORIGINAL ARTICLE  UDC: 617.7-005.1-085.357.55
Correspondence to:
Dragan VUKOVIĆ
Clinic of Eye Diseases
Clinical Center of Serbia
Pasterova 2, 11000 Belgrade
Serbia
draganv@beotel.net
SUMMARY
Introduction The course and prognosis of vitreous hemorrhage (VH) are difficult to predict in spite of 
so far published experimental and clinical studies.
Objective The goal of this study was to follow the course and evaluate prognosis of vitreous hemorrhage.
Methods The experiment was performed on 19 Chinchilla rabbits (Oryctolagus cuniculus), both males and 
females (38 eyes), weighing 2500-3000 g, which were treated with autologous blood (B) from marginal 
ear vein – the first group, and the second group was treated with both blood and corticosteroids (B+CS). 
The course of vitreous hemorrhage was examined.
Results Our results have shown that the cellular reaction to vitreous hemorrhage is different, compared 
to hemorrhage in other types of tissue, which is due to absence of an early polymorphonuclear cellular 
reaction. Number of cells within vitreous body is very low.
Conclusion Vitreous hemorrhage has unusual course followed by a small number of cells (mostly poly-
morphonuclear cells). This is most important fact why VH is cleared very slowly (about 6 to 9 weeks). CS 
has moderate influence on the acceleration of VH absorption.
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INTRODUCTION
In our practice it is very difficult to predict fi-
nal results when vitreous hemorrhage (VH) is 
present. This was the main accelerator to con-
duct this experiment and show the real influ-
ence of CS in the clearance rate of VH using 
Chinchilla rabbits. Hemorrhage within the 
vitreous body in all cases originates from the 
periphery, or from the vessels penetrating into 
the vitreous in certain pathological conditions, 
thus leading to the condition known as vitreous 
hemorrhage, or hemophthalmus.
Vitreous is a dilute meshwork of collagen 
fibrils interspersed with the extensive arrays 
of hyaluronan molecules. The collagen fibrils 
provide a scaffold-like structure that is inflat-
ed by the hydrophilic hyaluronan. If collagen 
is removed, the remaining hyaluronan forms 
a viscous solution. However, if hyaluronan is 
removed, the gel shrinks but is not destroyed. 
Electrostatic binding occurs between the neg-
atively charged hyaluronan and the positively 
charged collagen in the vitreous [1].
Studies have shown that the chondroitin sul-
fate chains of type IX collagen bridge between 
the adjacent collagen fibrils in a ladder-like 
configuration spacing them apart [2]. Such 
spacing is necessary for vitreous transparency, 
because keeping vitreous collagen fibrils sepa-
rated by at least one wavelength of incident 
light minimizes light scattering, allowing the 
unhindered transmission of light to the retina 
for photoreception [3].
The vitreous forms a diffusion coefficient 
that allows drug and hemorrhage to remain.
Various enzymes have been investigated to 
dissolve the vitreous hemorrhage or modify the 
structural characteristics of the vitreous to al-
low diffusion of blood out of the visual axis.
Vitreous collagens are organized into fibrils 
with types V/XI residing in the core, type II 
collagen surrounding the core, and type IX col-
lagen on the surface of the fibril. The fibrils are 
7 to 28 nm in diameter, but their length in situ 
is unknown. Studies have shown that the vitre-
ous contains collagen type II, a hybrid of types 
V/XI, and type IX collagen in a molar ratio of 
75:10:15, respectively [4].
The primary role of corticosteroids is mini-
mization of the inflammatory response. Their 
action is, according to modern knowledge, lo-
cal, which means corticosteroids must be at the 
site of infection. There, corticosteroids lessen 
increased permeability of endothelial capillary 
cells, thus reducing the leakage of fluids and 
proteins transport at the site of lesion. The glu-
cocorticoid receptor (GR) is a protein that me-
diates the actions of all pharmaceuticals. GRs 
regulate metabolism and are most well known 
for their role in inflammation [5]. It is at the 
very top of the inflammation pathway work-
ing in a multidirectional manner to subside 
inflammation. There are eight GR subtypes, 
and all are produced from a single messenger 
RNA [6, 7]. 
Injection of CS into the vitreous cavity sta-
bilizes blood retinal barrier and helps clearing      
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the vitreous hemorrhage. Dexamethasone in humans ap-
pears to have 4-month clinical duration, but in animals 
and in vitro it lasts to 6 months. There is a lack of basic 
understanding of the GR biochemistry in the eye, in terms 
of types of cells and their functions and, therefore, more 
research is required [5]. 
The assessment of hemolysis was based on its cardinal 
sign – vitreous opacification. Fibrinolysis was indirectly 
assessed by analyzing the size of the coagulum.
OBJECTIVE
Cellular response to vitreous B(blood), B+CS (blood + cor-
ticosteroid) was analyzed by counting and establishing an 
average cell number seen within 3 visual fields at char-
acteristic spots, using large magnification (400×), evalu-
ating the natural course of vitreous hemorrhage through 
coagulum disintegration and any modifications probably 
induced by CS.
METHODS
The experiment was carried out on 19 adult Chinchilla 
rabbits (Oryctolagus cuniculus) of both sexes, weighing 
2500-3000 g. The animals were anesthetized by intramus-
cular injection of ketamine hydrochloride, using dose of 
14-15 mg/kg. Both eyes were softened by withdrawal of 
0.15 ml of liquid vitreous using 27-gauge needle and tu-
berculin syringe. By means of plastic silicone coated sy-
ringe, 0.2 ml of full autologous blood was collected from 
the marginal ear vein without using anticoagulants. The 
blood was immediately injected into the central part of the 
vitreous body, using standardized procedure of via pars 
plana approach to the upper temporal quadrant, 3 mm 
away from the limbus. The procedure was performed un-
der ophthalmoscopic control and using 27-gauge needle. 
Eyeballs were perforated by sclerotomy, in all cases using 
19 gauge needle and pars plana approach, 3 mm away from 
the limbus in the upper temporal quadrant.
The animals (eyes) were categorized into two basic 
groups: first group (right eyes) – full autologous blood was 
injected into the central vitreous body only; second group 
(left eyes) – full autologous blood was administered, plus 
0.15 ml of intravitreous dexamethasone sodium phosphate 
(Dexason, ICN Galenika) or 0.3 mg through the same in-
cision through sclera, 7 minutes and 7 days after injec-
tion of full blood, respectfully. The first group of eyes, in 
which blood was injected and the evolution of coagulum 
was analyzed in detail, was at the same time the control 
group to another group of animals (eyes), which suffered 
the same traumatic procedure of intravitreous injection of 
blood, and B+CS.
All experimental animals received blood injection in a 
manner described above, while group 2 was administered 
0.15 ml of dexamethasone solution intravitreally, in the 
way that one subgroup received it after 5 minutes and an-
other after 7 days. 
An experimental group, intended for assessment of 
possible adverse effects of ocular trauma (or mini control 
group), consisted of 2 rabbits (4 eyes). In that group, an 
experimental wound was created on the right eye of the 
first rabbit, in pars plana, 3 mm away from the limbus, us-
ing 27-gauge needle. On the left eye, a wound was created 
using 19-gauge needle, 3 mm away from the limbus, with 
simultaneous intravitreous injection of 0.2 ml of physi-
ological normal saline solution In the second rabbit, pars 
plana wound of the right eye was created using 27-gauge 
needle, with simultaneous aspiration of 0.15 ml of liquid 
vitreous substance. On the left eye, 3 mm away from the 
limbus, a wound was created using 19-gauge needle, with 
simultaneous injection of 0.2 ml of normal physiological 
solution.
A mini control group was evaluated using ophthal-
moscopy and in certain periods of time the eyeballs were 
frozen in acetone after enucleation, and then anatomically 
and physiologically analyzed.
The interventions were completed by administration of 
1% atropine solution and 1% chloramphenicol oil suspen-
sion into the conjunctival sac.
Based on literature [8, 9], time intervals after which it 
was found that the material was useful for investigation 
were: 5 minutes, 6 days, 2, 3, 4, 6, 9, 10, and 12 weeks after 
intravitreous injection of blood.
The animals were eutinized using ketamine overdose 
or by causing gas embolism.
Blood clearance from the vitreous body was assessed 
weekly, using an indirect ophthalmoscopy and making 
drawings of the observed image, until week 12 after in-
travitreous injection of blood. In addition, drawing of 
ophthalmoscopic findings was made 5 minutes after the 
intravitreous injection of blood.
The eyeballs were enucleated using standard technique.
Twenty-four eyeballs were immediately placed into 
4% neutral buffered formaldehyde for fixation, while 9 
eyeballs (rabbit 6 had only one eye) were frozen in PVC 
bags with acetone, by application of liquid nitrogen for 
30 seconds.
The eyeballs fixed in formaldehyde were cut through 
the frontal plane, behind the lens, while the eyeballs fro-
zen in acetone were cut vertically, through the sagittal 
plane, so the topographic characteristics of changes in 
vitreous body would remain preserved. For histological 
analysis, vitreous coagula together with the surround-
ing tissue, wedge-like slices of eyeball tissue with parts 
of ciliary body and adjacent tissue, parts of retina, as well 
as granulomas or vitreoretinal proliferative bands, if any, 
were sampled.
All slices were stained using haematoxylin & eosin 
(HE), periodic acid-Schiff (PAS) and van Gieson (VG) 
staining methods.
For data analysis, the following statistical methods 
were used: structural analysis, average, standard devia-
tion, standard error of the average, confidence interval for 
p=0.95, Kaplan-Meier test, trend lines and trend errors, 
correlation coefficient (r), determination coefficient (r2), 
and indetermination coefficient (1-r).  
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RESULTS
Two groups of eyes (rabbits) were examined: those treated 
with blood only (B), and those treated with blood and corti-
costeroids (B+CS). Ophthalmoscopic appearance of vitreous 
body was recorded using drawings in two groups of eyes.
The extent of vitreous blood elimination, which was 
assessed ophthalmoscopically, was arbitrarily segregated 
in five stages: stage 1 – total vitreous opacity; stage 2 – in-
creased red reflex; stage 3 – fundus is visible through the 
patchy vitreous opacities; stage 4 – central vitreous is clean 
with the presence of small residual opacities; and stage 5 – 
totally clean vitreous.
The characteristics of elimination processes in two 
groups treated with B and B+CS were shown in Graphs 
1 and 2. In rabbits treated with blood only, the changes 
of vitreous opacities started during week 4 after the injec-
tion. Almost all rabbits, which survived the experiment, 
reached stages 4 or 5 (considering it normal finding) after 
week 6, as shown in Graph 1. The course of the vitreous 
hemorrhage after injection of B+CS was shown in Graph 2. 
Vitreous clearance started in the third week, while all rab-
bits, which survived, reached stages 4 or 5 after the week 3.
Table 1 shows that, when the injected substance was 
blood, the coagulum gradually decreased from the initial 8.0 
mm2 during the first 5 minute to 1 mm2 after the week 10. 
Table 2 shows that, when the injected substance was blood 
with corticosteroids, the coagulum gradually decreased from 
the initial 7.5 mm2 during the first week, to 3 mm2 during 
the sixth week, to become immeasurable in the week 9. We 
could not explain what happened at week 4, when coagulum 
paradoxically increased about 7.0 mm2 and then gradually 
decreased to become immeasurable in the week 9. Fibrinoly-
sis as a function of coagulum reduction, in cases when blood 
was injected, had a form of the second order polynomial: 
Yt=0.0535X2-1.1591X+6.9746, with a trend error SYt=0.77, 
which could be used for interpolation and extrapolation of 
data in the cases having the characteristics of the analyzed 
specimen. The correlation of the coagulum size and time in 
weeks, in cases when the blood was injected (Table 1) was 
highly significant (r=0.95; p<0.001). Explanatory factor of 
time impact (in weeks) on the reduction of the size of the 
coagulum was 91.2%, while the remaining 8.8% of variabil-
ity was attributed to other factors. Using the same analysis 
in cases when blood and corticosteroids were injected (Table 
2), the following for B+CS was obtained (94.6% to 5.4%).
The cellular response to vitreous B and B+CS was ana-
lyzed by counting and establishing an average cell number 
seen within 3 visual fields at characteristic spots, using 
large magnification (400×). De facto, the center of coagu-
lum, its periphery, and locations adjacent to ciliary body 
and retina were analyzed, by counting the polymorpho-
nuclear (PMN) cells, mononuclear cells, macrophages, as 
well as fibroblasts and plasma cells. Tables 3 and 4 show 
the results of examination of coagulum center, coagulum 
periphery, area adjacent to ciliary body and area adjacent 
to retina in cases when B and B+CS were injected. Table 3 
shows cellular appearance by number and type of cells in 
the center of coagulum when B was injected, when there 
were 3 PMN cells, 1 mononuclear cell, and no macrophag-
es after five minutes of blood injection. Table 4 shows the 
results of examination of coagulum center when blood and 
corticosteroid were injected, where we can see situation 
similar to that seen in cases when blood alone was inject-
ed. Herein, more than 10 PMN, mononuclear cells, and 
macrophages in the week 4, as well as one mononuclear 
leukocyte during the week 10 can be noted.
Table 1. Fibrinolysis in function of coagulum reduction – blood as 
an injectant
Time Size of the coagulum (mm2)
5 minutes 8
Week 1 5.5
Week 2 4.5
Week 3 3
Week 4 Not measured
Week 6 2
Week 9 2
Week 10 1
Week 12 0
Table 2. Fibrinolysis in function of coagulum reduction – blood and 
corticosteroids as an injectant
Time (week) Size of the coagulum (mm2)
1 7.5
2 5
3 4
4 7
6 3
9 0
10 0
12 0
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Graph 2. Blood and corticosteroids as an injectant
Each bar represents the eye of one rabbit while their peaks represent the end 
of examination period when the rabbit was eutanized
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Graph 1. Blood as an injectant
Each bar represents the eye of one rabbit, while its peak represents the end of 
examination period when the rabbit was eutanized.     
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DISCUSSION
This type of experiment which we have done is very dif-
ficult to perform. But, every experiment has many ele-
ments of variability. Findings may vary significantly from 
section to section of tissue in our experiment and the re-
sults have to be taken with a grain of salt. The findings 
of other authors are more or less unreliable, too. Results 
that we need cannot be obtained from human materials 
alone. Clinically, we can follow vitreous hemorrhage in 
humans, but histologically it is almost impossible to get 
human vitreous samples. We hope that our histological 
findings obtained from animals will give some insight into 
better clinical understanding of vitreous hemorrhage. The 
inflammatory cell response can be followed by counting 
radio-labeled cells. Echo may be used as a supplement 
method to indirect ophthalmoscopy to follow the clinical 
stages of vitreous hemorrhage. These methods were not 
available to us during the time of our experimental work. 
Nevertheless, in our opinion, these results are the best that 
can be obtained from the methodological technique used 
in our experimental work.
If the injected substance, as mentioned above, was al-
ways the same amount of autologous blood (0.2 ml), we 
had an opportunity to determine the area of the coagulum 
by measuring its length and width using the gross-ana-
tomical specimens (this can be also seen in the anatomical 
photographs), and therefore gaining the comparable pa-
rameter for the analysis in our experiment. Table 1 shows 
that, when blood was injected, the size of coagulum started 
to decrease five minutes after the blood injection, from 8 
mm2 to negligible size of 1 mm2 after the week 10.
The results of comparison of opacity, between the group 
with blood only and the group with blood and CS, suggest 
that the corticosteroids were significantly superior in vit-
reous clearance rate. The results were obtained using the 
Kaplan-Meier test; they suggested that the probability for 
all vitreous bodies to clear before the fifth week was 100% 
in cases where blood was injected. The probability of 100% 
for all vitreous specimens to clear was reached in week 4 in 
cases when B+CS were injected. Similar course of vitreous 
hemorrhage may be noticed when comparing the Graphs 
1 and 2. Graph 1 represents the group of rabbits treated 
with blood only, and Graph 2 group of rabbits treated with 
blood and corticosteroid, as well as clearance in presence 
of corticosteroids compared to blood only (p<0.05). The 
probability of complete vitreous clearance when only blood 
was injected was 60% in the fourth week, and in case of 
both blood and corticosteroid injection, the probability 
was 100% in the fourth week. Five minutes after injec-
tion, the average number of cells seen on 3 visual fields, 
within the center of coagulum, was 3, for PMN cells, 1 for 
mononuclear cells, and none for macrophages. This sug-
gests that these cells did not migrate into the vitreous, but 
were introduced by injection.
In the first week of assessing cellular dynamics after 
blood injection, no PMN cell, no mononuclear cell, and 
no macrophages were observed. In the second week of as-
sessing cellular dynamics after blood injection, 1 PMN cell, 
1 mononuclear cell, and no macrophages were observed. 
Until week 12 of the experiment, no cells within the center 
of coagulum were observed (Table 3). The sections of fi-
brin clots and their central areas, in case where blood and 
corticosteroid were injected into the vitreous (Table 4), 
showed no PMN cells, mononuclear cells, or macrophages 
during the first week. In the fourth week, PMN, mononu-
clear, and macrophage mass became evident, followed by 
no cells in the sixth week. Week 9 was characterized by the 
absence of any cells. In the week 10, there were 0 PMN, 1 
mononuclear cell, and no macrophages in 3 visual fields, 
when large magnification was used to examine the central   
coagulum. In the week 12, no cells of any type were ob-
served.
Considering the fact that coagulum in rabbit skin is 
removed within week or two [3] in abundant presence of 
PMN cells, and that the same process in vitreous takes 6-9 
weeks in presence of an extremely small number of PMN 
cells, we may conclude that the reason for slow fibrin elimi-
nation is complete absence or modest amount of PMN 
cells, which is compatible with the results of other authors 
[10-13]. The absence of significant PMN cellular reaction, 
which, in fact, facilitates fibrin disintegration, results in 
slow vitreous fibrin elimination. Furthermore, this leads to 
fibrin degradation products, which are known to stimulate 
PMN cellular migration [14, 15, 16].
CONCLUSION
Analyzing the obtained results from our experimental 
study, whose purpose was to demonstrate normal intravit-
reous hemorrhage evolution over the successive periods of 
time, as well as to assess any possible modifications caused 
by corticosteroids, we can conclude that normal intravitre-
ous hemorrhage evolution differs from other types of he-
morrhage affecting the tissues other than eye, by following 
characteristics: slow fibrinolysis, and the absence of an early 
polymorphonuclear cellular response to vitreous hemor-
rhage.
Vitreous blood clearance will start one week earlier in 
the presence of corticosteroids compared to the clearance 
when no corticosteroids are administered. 
Vitreous response to presence of coagulum is charac-
terized by the absence of inflammatory cells penetration 
into the coagulum, and by persistence of coagulum until 
week 4. 
The loss of coagulum fibrin network is not observed 
before week 4-6 after the injection of blood. Accordingly, 
it is reasonable to wait at least 6 weeks for spontaneous 
clearance of vitreous hemorrhage.
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КРАТАК САДРЖАЈ
Увод Ток и прог  но  зу ви  тре  ал  ног кр  ва  ре  ња те  шко је пред-
ви  де  ти упр  кос по  да  ци  ма до  ступ  ним у об  ја  вље  ним екс  пе  ри-
мен  тал  ним и кли  нич  ким сту  ди  ја  ма.
Циљ ра  да Циљ ра  да је био да се пра  ти ток и са  гле  да прог-
но  за ви  тре  ал  ног кр  ва  ре  ња.
Ме  то  де ра  да Екс  пе  ри  мент је из  ве  ден на 19 чин  чи  ла ку  ни  ћа 
(Orycto la gus cu ni cu lus) оба по  ла (38 очи  ју), те  жи  не 2500–3000 
гра  ма, ко  ји  ма је у очи убри  зга  на ауто  лог  на крв из ивич  не 
ве  не ува (пр  ва гру  па жи  во  ти  ња), од  но  сно ауто  лог  на крв и 
кор  ти  ко  сте  ро  ид  ни рас  твор (дру  га гру  па). Пра  ћен је и ана-
ли  зи  ран ток ви  тре  ал  не хе  мо  ра  ги  је.
Ре  зул  та  ти Ре  зул  та  ти екс  пе  ри  мен  та су по  ка  за  ли да је ће-
лиј  ска ре  ак  ци  ја на ви  тре  ал  но кр  ва  ре  ње раз  ли  чи  та у по  ре-
ђе  њу с кр  ва  ре  њи  ма у дру  гим тки  ви  ма, пр  вен  стве  но због 
из  о  стан  ка ра  не по  ли  мор  фо  ну  кле  ар  не ће  лиј  ске ре  ак  ци  је. 
Број ће  ли  ја уну  тар ви  тре  ал  ног про  сто  ра био је ве  о  ма ма  ли.
За  кљу  чак Ви  тре  ал  на хе  мо  ра  ги  ја има спе  ци  фи  чан ток пра-
ћен ма  лим бро  јем ће  ли  ја (углав  ном по  ли  мор  фо  ну  кле  ар-
ним ће  ли  ја  ма). То је глав  ни раз  лог за  што се ин  тра  ви  тре  ал  но 
кр  ва  ре  ње ре  сор  бу  је ве  о  ма спо  ро (про  сеч  но, из  ме  ђу шест 
и де  вет не  де  ља). Кор  ти  ко  сте  ро  и  ди има  ју уме  рен ути  цај на 
убр  за  ње ап  сорп  ци  је ви  тре  ал  не хе  мо  ра  ги  је.
Кључ  не ре  чи: ви  тре  ал  на хе  мо  ра  ги  ја; при  род  ни ток; кор  ти-
ко  сте  ро  и  ди; зе  че  ви
Природни ток експерименталне витреалне хеморагије и утицај 
кортикостероида на њен ток
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